北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 8/9/11/F, Emperor Group Centre, No.12D, Jianwai Avenue, Chaoyang District, Beijing, 100022, P.R.China 电话/Tel:010-50867666 传真/Fax:010-56916450 网址/Website:www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 北京康达（宁波）律师事务所 关于嘉兴中润光学科技股份有限公司 2024 年年度股东会的法律意见书 康达股会字 2025 第 0047 号 致：嘉兴中润光学科技股份有限公司 北京康达（宁波）律师事务所（以下简称"本所"）接受嘉兴中润光学科技 股份有限公司（以下简称"公司"）的委托，指派本所律师参加公司 2024 年年度 股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券 ...

证券代码：688307 证券简称：中润光学 公告编号：2025-017 嘉兴中润光学科技股份有限公司 关于新增募集资金专户并签订监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 根据中国证券监督管理委员会于 2022 年 12 月 5 日签发的《关于同意嘉兴中 润光学科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕3064 号），公司获准向社会公开发行人民币普通股（A 股）股票 2,200 万股，每股面 值 1 元，每股发行价格为人民币 23.88 元，募集资金总额为人民币 525,360,000.00 元，扣除发行费用人民币 79,189,860.99 元，实际募集资金净额为 446,170,139.01 元，上述募集资金已于 2023 年 2 月 10 日汇入公司募集资金监管账户，由天健会 计师事务所（特殊普通合伙）审验，并出具验资报告（天健验（2023）47 号）。 上述募集资金到账后，公司对募集资金的存放和使用进行专户管理，且已与保荐 机构、存放募集资金的银行签 ...

嘉兴中润光学科技股份有限公司 2024 年年度股东大会会议资料 公司代码：688307 公司简称：中润光学 嘉兴中润光学科技股份有限公司 2024 年年度股东大会会议资料 为维护广大投资者的合法权益，确保本次股东大会如期、顺利召开，保障股东在 本次股东大会期间依法行使权利，根据《中华人民共和国公司法》《中华人民共和国 证券法》《上市公司股东大会规则》《嘉兴中润光学科技股份有限公司章程》以及《嘉 兴中润光学科技股份有限公司股东大会议事规则》等有关规定，嘉兴中润光学科技股 份有限公司（以下简称"公司"）特制定本会议须知： 一、会议期间，全体出席人员应以维护股东的合法权益、保证大会的正常秩序和 议事效率为原则，认真履行法定义务，自觉遵守大会纪律，不得侵犯公司和其他股东 的合法权益，不得扰乱股东大会的正常召开秩序。 2025 年 4 月 | | | | 2024 年年度股东大会会议须知 . | | --- | | 2024 年年度股东大会会议议程 . | | 2024 年年度股东大会会议议案 . | | 议案一：关于 2024年度董事会工作报告的议案 | | 议案二:关于 2024年度监事会工作报告的议案 | | 议 ...

Core Viewpoint - Zhongrun Optical (688307) has experienced a decline in stock price, closing at 27.45 yuan, down 5.51% from the previous week, with a current market capitalization of 2.416 billion yuan [1] Shareholder Changes - As of February 28, 2025, the number of shareholders for Zhongrun Optical is 6,206, an increase of 192 from December 31, 2024, representing a growth rate of 3.19%. The average number of shares held per shareholder decreased from 14,600 to 14,200 shares, with an average holding value of 434,900 yuan [2][6] Performance Disclosure - The 2024 annual report for Zhongrun Optical shows a main revenue of 455 million yuan, a year-on-year increase of 20.01%. The net profit attributable to shareholders is 53.43 million yuan, up 47.06% year-on-year, while the net profit excluding non-recurring items is 46.37 million yuan, an increase of 51.24%. In Q4 2024, the main revenue was 136 million yuan, down 5.64% year-on-year, with a net profit of 15.78 million yuan, down 32.72% year-on-year [3] Company Announcements - Zhongrun Optical plans to distribute a cash dividend of 3.50 yuan (including tax) for every 10 shares, totaling 30.80 million yuan (including tax), which accounts for 57.65% of the net profit attributable to shareholders for 2024. Additionally, a cash dividend of 1.00 yuan (including tax) per 10 shares will be distributed in 2024, totaling 8.80 million yuan (including tax), which represents 74.12% of the net profit for the year [4][6]

证券代码：688307 证券简称：中润光学 公告编号：2025-007 嘉兴中润光学科技股份有限公司 关于召开 2024 年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024 年年度股东大会 召开日期时间：2025 年 4 月 18 日 14 点 30 分 召开地点：浙江省嘉兴市秀洲区高照道陶泾路 188 号 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 至 2025 年 4 月 18 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东大会召 开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联网投票平台的投票时 间为股东大会召开当日的 9:15-15:00。 （六） 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序涉及融资融券、 转融通业务、约定购回业务相关账户以及沪股通投资者的投票，应按照《上海证券交 ...

不触及《上海证券交易所科创板股票上市规则》（以下简称《科创板股票 上市规则》）第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警示的情 形。 一、2024 年度利润分配方案的基本情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股分配比例：每 10 股派发现金红利人民币 3.50 元（含税），不进行公 积金转增股本，不送红股。 本次利润分配以实施权益分派股权登记日的总股本为基数，具体日期将在 权益分派实施公告中明确。 若在实施权益分派的股权登记日前公司总股本发生变动的，拟维持分配总 额不变，相应调整每股分配金额，并将另行公告具体调整情况。 证券代码：688307 证券简称：中润光学 公告编号：2025-005 嘉兴中润光学科技股份有限公司 2024 年度利润分配方案的公告 经天健会计师事务所（特殊普通合伙）审计，截至 2024 年 12 月 31 日，嘉 兴中润光学科技股份有限公司（以下简称"公司"）归属于上市公司股东的净利 润为 53,429,778.84 元，母公司未分配利润为 80, ...

嘉兴中润光学科技股份有限公司 2024 年度独立董事述职报告（朱朝晖） 作为嘉兴中润光学科技股份有限公司（以下简称"公司"）的独立董事，2024 年度本人严格按照《中华人民共和国公司法》（以下简称"《公司法》"）《中 华人民共和国证券法》（以下简称"《证券法》"）《上市公司独立董事管理办 法》（以下简称"《管理办法》"）《上海证券交易所科创板股票上市规则》（以 下简称"《上市规则》"）等法律法规及《嘉兴中润光学科技股份有限公司章程》 （以下简称"《公司章程》"）《独立董事工作制度》等规定，勤勉尽责、恪尽 职守，积极履行独立董事职责，积极参加公司各项会议，充分发挥独立董事的作 用，推动公司高质量发展，切实维护了公司和全体股东的合法权益，积极促进公 司规范运作和治理水平的提升。现将2024年度履行独立董事职责的情况报告如下： 一、独立董事基本情况 （三）是否存在影响独立性的情况说明 作为公司的独立董事，经自查，本人符合现行《上市公司独立董事管理办法》 《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》中对独立 董事独立性的相关要求。 1 本人及直系亲属均不持有本公司股份，未在公司担任除独立董事外的其他 ...

证券代码：688307 证券简称：中润光学 公告编号：2025-005 嘉兴中润光学科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 每股分配比例：每 10 股派发现金红利人民币 3.50 元（含税），不进行公 积金转增股本，不送红股。 ? 若在实施权益分派的股权登记日前公司总股本发生变动的，拟维持分配总 额不变，相应调整每股分配金额，并将另行公告具体调整情况。 二、是否可能触及其他风险警示情形 ? 本次利润分配以实施权益分派股权登记日的总股本为基数，具体日期将在 权益分派实施公告中明确。 ? 不触及《上海证券交易所科创板股票上市规则》（以下简称《科创板股票 上市规则》）第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警示的情 形。 本次利润分配符合相关法律法规及公司章程的规定，不触及《科创板股票上 市规则》第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警示的情形， 相关数据及指标如下表： 一、2024 年度利润分配方案的基本情况 | 项目 本年度 | | 上年 ...

Fundraising Overview - The company raised a total of RMB 525.36 million by issuing 22 million shares at RMB 23.88 per share, with a net amount of RMB 446.17 million after deducting issuance costs of RMB 79.19 million, which was deposited into a dedicated fundraising account on February 10, 2023 [1][2] - As of December 31, 2024, the balance in the fundraising account was RMB 4.27 million, with a total of RMB 44.62 million raised and utilized for various projects and working capital [2][3] Fund Utilization - The company allocated RMB 7.21 million for project investments and RMB 8 million for working capital, with an additional RMB 1.2 million from oversubscribed funds permanently supplementing working capital [2][3] - The total amount utilized for project investments reached RMB 10.30 million, while the cash management activities generated a net interest income of RMB 1.46 million [2][3] Fund Management - The company established a fundraising management system to ensure compliance with relevant regulations and protect investor interests, including a tripartite supervision agreement with banks and the sponsor [3][4] - As of December 31, 2024, the company had not used idle fundraising for temporary working capital and had engaged in cash management with a balance of RMB 24.65 million, primarily in high-security, liquid investment products [4][5] Project Status and Adjustments - The company approved the use of RMB 6.68 million of fundraising to replace pre-invested project funds and RMB 0.57 million for issuance costs [4][5] - The high-end optical lens intelligent manufacturing project and the R&D center upgrade project have been delayed, with the expected completion date adjusted to December 2026 due to market conditions and project progress [8][9] Compliance and Audit - The company has adhered to all relevant laws and regulations regarding fundraising usage, with no violations reported [10][11] - The sponsor confirmed that the management of fundraising and its usage complied with regulatory requirements, with no changes in the purpose of the funds that could harm shareholder interests [11]

Financial Performance - The company achieved total operating revenue of CNY 454.66 million in 2024, representing a year-on-year growth of 20.01%[23]. - Net profit attributable to shareholders reached CNY 53.43 million, an increase of 47.06% compared to the previous year[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 46.37 million, up 51.24% year-on-year[23]. - The company's basic and diluted earnings per share increased by 41.86% to CNY 0.61[24]. - The weighted average return on net assets rose to 6.30%, an increase of 1.45 percentage points from the previous year[24]. - The company reported a net cash flow from operating activities of CNY 106.47 million, slightly up by 0.95% from the previous year[23]. - The total assets of the company at the end of 2024 were CNY 1,051.93 million, reflecting a 3.38% increase from the previous year[23]. - The company achieved total revenue of 454.66 million RMB in 2024, a year-on-year increase of 20.01%[36]. - The net profit attributable to shareholders of the parent company was 53.43 million RMB, reflecting a year-on-year growth of 47.06%[36]. - The company reported a total asset value of 1,051.93 million RMB, an increase of 3.38% compared to the previous year[36]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 3.50 per 10 shares, totaling RMB 30.8 million, which represents 57.65% of the net profit attributable to shareholders for 2024[6]. - For the first half of 2024, the company distributed a cash dividend of RMB 1.00 per 10 shares, totaling RMB 8.8 million, and plans to distribute a total of RMB 39.6 million for the entire year, accounting for 74.12% of the net profit attributable to shareholders[7]. - The total cash dividends for 2024 are projected to be RMB 39.6 million, accounting for 74.12% of the net profit attributable to shareholders for the year[169]. - The company has maintained a consistent cash dividend policy, with a cumulative cash dividend of RMB 39.6 million over the last three fiscal years[175]. Research and Development - Research and development expenses accounted for 10.69% of operating revenue, maintaining the same percentage as the previous year[24]. - The company increased R&D investment to CNY 48.6044 million, representing 10.69% of revenue, a growth of 19.96% compared to 2023[39]. - The company applied for 14 patents in 2024, including 12 invention patents, and received a total of 29 authorized patents, with 26 being invention patents[39]. - The total R&D investment for the year was approximately ¥48.6 million, representing a 19.96% increase from the previous year, with R&D expenses accounting for 10.69% of operating revenue[67]. - The company has established a comprehensive R&D system and an international R&D team, integrating resources from three major R&D centers in Jiaxing, Taiwan, and Japan to maintain technological leadership in optical lens design[49]. - The company is focusing on developing advanced optical lenses, including glass aspheric lenses and hybrid lenses, to meet the growing demand for high-quality imaging[56]. - The company has developed core technologies applied in various fields such as smart monitoring, intelligent detection, and high-definition imaging, enhancing its competitive edge[75]. Market Expansion and Product Development - The company is expanding its product offerings in the drone industry, focusing on consumer-grade drones and medical detection products[38]. - The company is focusing on high-resolution fixed-focus, star-level fixed-focus, and optical stabilization technologies to bridge the gap with international advanced levels in high-end optical lenses[61]. - The company is developing new products for smart home and smart driving applications, enhancing its market share in these areas[129]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of the next fiscal year[146]. - The company aims to enhance its technological capabilities and service quality to remain competitive in the rapidly evolving optical lens market[56]. Corporate Governance - The company emphasizes compliance with governance regulations and has held 3 shareholder meetings and 5 board meetings during the reporting period[136][137]. - The company has established a strategic committee, audit committee, nomination committee, and compensation committee to support board decision-making[137]. - The company’s controlling shareholder has adhered to regulations, ensuring no interference in company decisions or operations[139]. - The company is committed to maintaining compliance with relevant laws and regulations governing listed companies[140]. - The board of directors and management team have remained stable, with no significant changes in shareholding[144]. Risk Management - The company has detailed various risks and countermeasures in its annual report, which can be found in the section on risk factors[3]. - The company has established a risk management mechanism to identify, assess, and respond to potential risks, enhancing internal audit and control effectiveness[187]. - The company faces risks related to new product development and technology iteration, which are critical for maintaining its market position[78]. - The company faces risks related to customer concentration, with the top five customers accounting for 51.78% of total revenue, a slight decrease of 0.42 percentage points from the previous year[81]. Social Responsibility and Sustainability - The company actively participated in social responsibility initiatives, donating 50,000 yuan to the Xiuzhou District Charity Association and 100,000 yuan to the Zhejiang University Education Foundation during the reporting period[193]. - The company is committed to sustainable development, implementing energy-saving and waste reduction measures, and obtaining ISO 14001 certification for its environmental management system[192]. - The company prioritizes sustainable procurement practices, selecting environmentally friendly materials and collaborating with suppliers to promote a green supply chain[194]. - The company invested 185,000 RMB in environmental protection during the reporting period[195]. - The company is not listed as a key pollutant discharge unit by environmental protection authorities[196]. Employee Development - The company emphasizes talent development, having introduced 10 master's graduates and trained 6 senior and mid-level professionals during the reporting period[41]. - The company has a total of 164 R&D personnel, accounting for 22.28% of the total workforce[41]. - The company has established a differentiated compensation structure based on job responsibilities and performance, ensuring fairness and competitiveness in employee remuneration[165]. - The training program is designed to be comprehensive and personalized, focusing on the development needs of employees at different levels and positions[166].